- Home
- SLNO vs GDV Comparison
SLNO vs GDV Comparison
Compare SLNO & GDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLNO | GDV |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | SLNO | GDV |
|---|---|---|
| Price | $39.79 | $29.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $112.70 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 186.0K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.81% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $98,675,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $159.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.95 | $18.04 |
| 52 Week High | $90.32 | $23.00 |
Technical Indicators
Market Signals| Indicator | SLNO | GDV |
|---|---|---|
| Relative Strength Index (RSI) | 40.84 | 70.67 |
| Support Level | $39.23 | $28.55 |
| Resistance Level | $41.84 | $29.45 |
| Average True Range (ATR) | 2.02 | 0.34 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 21.76 | 89.06 |
Price Performance
Historical ComparisonAbout SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.